Tag: DCGI
  • Health
    • Zydus Applies to the DCGI for EUA to Launch ZyCoV-D

    AHMEDABAD:Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to.

    July 5, 2021
  • Health
    • Glenmark Launch Remogliflozin + Vildagliptin Fixed Dose Combination for Type 2 Diabetes

    KOCHI:Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination.

    January 5, 2021
  • Health
    • BDR Receives DCGI Approval for Favipiravir to Treat COVID-19

    MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.

    August 5, 2020
  • Health
    • Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir

    KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.

    May 14, 2020